# Neal I. Lindeman

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/neal-i-lindeman/

## Facts

| Field | Value |
| --- | --- |
| Citations | 43,668 |
| Field | Cancer Genomics and Diagnostics |
| h-index | 71 |
| i10-index | 165 |
| Last Known Institution | Cornell University |
| OpenAlex ID | https://openalex.org/A5035004148 |
| ORCID iD | https://orcid.org/0000-0002-7092-6859 |
| Works | 486 |

## Researcher papers

- [<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy](https://scholariq.org/papers/i-egfr-i-mutations-in-lung-cancer-correlation-with-clinical-response-to/)
- [<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling](https://scholariq.org/papers/i-met-i-amplification-leads-to-gefitinib-resistance-in-lung-cancer-by-activating/)
- [AACR Project GENIE: Powering Precision Medicine through an International Consortium](https://scholariq.org/papers/aacr-project-genie-powering-precision-medicine-through-an-international/)
- [Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology](https://scholariq.org/papers/updated-molecular-testing-guideline-for-the-selection-of-lung-cancer-patients/)
- [Exon 19 Deletion Mutations of Epidermal Growth Factor Receptor Are Associated with Prolonged Survival in Non–Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib](https://scholariq.org/papers/exon-19-deletion-mutations-of-epidermal-growth-factor-receptor-are-associated/)
- [Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine](https://scholariq.org/papers/whole-exome-sequencing-and-clinical-interpretation-of-formalin-fixed-paraffin/)
- [Institutional implementation of clinical tumor profiling on an unselected cancer population](https://scholariq.org/papers/institutional-implementation-of-clinical-tumor-profiling-on-an-unselected-cancer/)
- [Bronchial and Peripheral Murine Lung Carcinomas Induced by T790M-L858R Mutant EGFR Respond to HKI-272 and Rapamycin Combination Therapy](https://scholariq.org/papers/bronchial-and-peripheral-murine-lung-carcinomas-induced-by-t790m-l858r-mutant/)

## Researcher topics

- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Genetic factors in colorectal cancer](https://scholariq.org/topics/genetic-factors-in-colorectal-cancer/)
- [Genomics and Rare Diseases](https://scholariq.org/topics/genomics-and-rare-diseases/)

## Researcher university

- [Cornell University](https://scholariq.org/institutions/cornell-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.